Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Complement C3/C3a/C3a Des-Arg anticorps

L’anticorps Souris Monoclonal anti- a été validé pour IA, FACS et WB. Il convient pour détecter dans des échantillons de Humain. Il y a 2+ publications disponibles.
N° du produit ABIN2191946

Aperçu rapide pour Complement C3/C3a/C3a Des-Arg anticorps (ABIN2191946)

Antigène

Complement C3/C3a/C3a Des-Arg

Reactivité

Humain

Hôte

Souris

Clonalité

Monoclonal

Application

Immunoassay (IA), Flow Cytometry (FACS), Western Blotting (WB)

Clone

2898
  • Stérilité

    0.2 μm filtered
  • Indications d'application

    For Western blotting, dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50. Positive Human plasma control Negative C3-depleted serum control 1

    Restrictions

    For Research Use only
  • Buffer

    PBS, containing 0.1 % bovine serum albumin and 0.02 % sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Product should be stored at 4 °C. Under recommended storage conditions, product is stable for at least one year. The exact expiry date is indicated on the label.
  • Smalley, Root, Cho, Ross, Ley: "Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles." dans: Thrombosis and haemostasis, Vol. 97, Issue 1, pp. 67-80, (2007) (PubMed).

    Hartmann, Lübbers, Casaretto, Bautsch, Klos, Köhl: "Rapid quantification of C3a and C5a using a combination of chromatographic and immunoassay procedures." dans: Journal of immunological methods, Vol. 166, Issue 1, pp. 35-44, (1993) (PubMed).

  • Antigène

    Complement C3/C3a/C3a Des-Arg

    Sujet

    The monoclonal antibody 2898 recognizes the C-terminus of human complement protein C3a. The antibody recognizes intact C3, C3a as well as C3a-desArg. C3 is the most abundant protein of the complement system with serum protein levels of about 1.3 mg/mL. The complement system is an important part of the humoral response in innate immunity, consisting of three different pathways. The third complement component, C3, is central to the classical, alternative and lectin pathways of complement activation. Activation products of the complement cascade contain neo-epitopes that are not present in the individual native components. Monoclonal antibodies detecting neo-epitopes have been used for direct quantification of activation at different steps in the complement cascade. The synthesis of C3 is tissue-specific and is modulated in response to a variety of stimulatory agents. An inherited deficiency of C3 predisposes the person to frequent assaults of bacterial infections. In ulcerative colitis, and idiopathic chronic inflammatory bowel disease, the deposition of C3 in the diseased mucosa has been reported. Proteolysis by certain enzymes results in the cleavage of C3 releasing C3a anaphylatoxin and C3b. C3a is a protein of 74 amino acids. C3a itself is very short-lived and in serum is cleaved rapidly into the more stable C3a-desArg (also called acylation stimulating protein, ASP). Therefore, measurement of C3a-desArg allows reliable conclusions about the level of complement activation in the test samples. C3a is a mediator of local inflammatory processes. It induces smooth muscle contraction, increases vascular permeability, and causes histamine release from mast cells and basophilic leukocytes. C3a is involved in inflammatory reactions seen in gram-negative bacterial sepsis, trauma, ischemic heart disease, post-dialysis syndrome and a variety of autoimmune diseases. Aliases Complement protein C3 Immunogen Peptide CARASHLGLA (last nine amino acids of C3a-desArg)
Vous êtes ici:
Chat with us!